Juvenile Myelomonocytic Leukemia
The information in this section about juvenile myelomonocytic leukemia (JMML) can help you talk with members of your child's healthcare team and take an active role in his or her treatment. Knowing what to expect and being able to make informed decisions about cancer treatment are important aspects of coping with the disease. You can skim sections to find what you want to read now - and continue reading whenever you're ready for more information.
What You Should Know
- JMML is an uncommon blood cancer.
- JMML is most commonly diagnosed in infants and children younger than 6 years old.
- Many individual factors influence outcomes.
- Hematologists and oncologists are specialists who treat people who have JMML or other types of blood cancer.
What You Should Do
- Talk with your doctor about your child's diagnostic tests and what the results mean.
- Seek treatment in a cancer center where doctors are experienced in treating patients with leukemia.
- Ask your doctor whether a clinical trial is a good treatment option for your child.
What Is JMML?
Juvenile myelomonocytic leukemia (JMML) is an uncommon blood cancer that can progress rapidly without treatment. It has features of two other types of blood cancers. For this reason, the World Health Organization (WHO) classifies JMML as a mixed myelodysplastic/myeloproliferative disease.
JMML occurs mostly in infancy and early childhood.
JMML is also called:
- juvenile chronic myelogenous leukemia
- chronic granulocytic leukemia
- CMML of childhood
- chronic and subacute myelomonocytic leukemia
- infant monosomy 7 syndrome